Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“Host-microbe interactions are opening new doors in cancer immunotherapy!
At SITC26, the cutting-edge session, ‘Microbiome and Metabolism‘, examines the microbiome’s growing role in cancer development, tumor immunity and response to therapy on Nov. 7.
Join Francesca Gazzaniga, PhD, Marlies Meisel, PhD, Bertrand Routy, MD, PhD, Maayan Levy, PhD, PhD and Golnaz Morad, DDS, PhD, as they discuss emerging technologies, key challenges and new opportunities at the intersection of microbiology, metabolism and cancer immunotherapy.
Other articles about Immunotherapy on OncoDaily.